Chromosome Disorders clinical trials
The registry lists 13 studies for Chromosome Disorders across 9 countries. 4 are recruiting or about to start. 4 of them are mainly about Chromosome Disorders (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06. Counting its 11 narrower conditions too, such as Down Syndrome: 952 studies, 201 open.
Get an email when these change. Save the Chromosome Disorders studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
University of California, Davis (2) · Maimonides Medical Center (1) · Cindy Cisneros (1) · Guangzhou Women and Children's Medical Center (1) · University of Alberta (1) · RTI International (1) · Assiut University (1) · Oregon Health and Science University (1)
What is being tested here
Drugs under test in Chromosome Disorders studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Lonapegsomatropin | 1 | 1 | 1 |
| Metformin | 0 | 1 | 2 |
| Guanfacine | 0 | 0 | 1 |
| Ketamine | 0 | 0 | 1 |
| Lovastatin | 0 | 0 | 1 |
| Melatonin | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Nov 2027Hematological Profile in Children With Numerical Chromosomal Disorders · Assiut University
Who these studies take
Of the 3 Chromosome Disorders studies recruiting now, 1 (33%) set no upper age limit and 2 (67%) stop at 75 or younger. 3 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 3 (100%) | 3 (100%) |
| 18 | 2 (67%) | 2 (67%) |
| 30 | 1 (33%) | 1 (33%) |
| 40 | 1 (33%) | 1 (33%) |
| 50 | 1 (33%) | 1 (33%) |
| 65 | 1 (33%) | 1 (33%) |
| 75 | 1 (33%) | 1 (33%) |
| 85 | 1 (33%) | 1 (33%) |
Across all 13 studies, recruiting or not: 77% stop at 75 or younger and 77% at 65; 92% take children; 15% are for women only and 0% for men only; 23% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 13 of 13. search them.
- Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient DisordersRecruitingNCT07221851Phase 37 countries
- Hematological Profile in Children With Numerical Chromosomal DisordersNot yet recruitingNCT07807540
- Collaboration for Down Syndrome Progress (CDP)RecruitingNCT076255791 country
- Diagnosis and Management of Intrauterine Growth Restriction and Congenital AnomaliesRecruitingNCT033986291 country
- The Contribution of Optical Mapping to the Characterization of Chromosomal Rearrangements in Patients With Neurodevelopmental DisordersCompletedNCT071337891 country
- A Trial of Metformin in Individuals With Fragile X Syndrome (Met)CompletedNCT03862950Phase 21 country
- A Trial of Metformin in Individuals With Fragile X SyndromeCompletedNCT03479476Phase 2/32 countries
- Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi SyndromeCompletedNCT05657860Phase 41 country
- Low-Dose Ketamine in Children With ADNP SyndromeCompletedNCT04388774Phase 1/21 country
- Non-Invasive Chromosomal Evaluation of Trisomy StudyCompletedNCT022018621 country
- Melatonin Levels in Smith Magenis Syndrome (SMS)TerminatedNCT00691574Not applicable1 country
- Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X SyndromeCompletedNCT02642653Phase 41 country
- Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal BloodStatus unknownNCT000645971 country